Medivir AB (publ) (STO:MVIR)
Sweden · Delayed Price · Currency is SEK 1.480
-0.070 (-4.52%)
Nov 2, 2026, 5:24 PM CET
Medivir AB Ratios and Metrics
Market cap in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 924 | 184 | 319 | 159 | 552 | 624 | |
Market Cap Growth | 1424.79% | -42.39% | 100.21% | -71.16% | -11.61% | 209.74% |
Enterprise Value | 675 | 167 | 236 | 110 | 424 | 411 |
Last Close Price | 1.55 | 0.41 | 2.84 | 2.85 | 8.11 | 9.18 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | 34.33 | 273.11 | 273.11 | 273.11 | 273.11 | 273.11 |
PS Ratio | 111.10 | 21.57 | 91.43 | 20.85 | 125.15 | 19.27 |
PB Ratio | 3.27 | 1.18 | 2.76 | 0.73 | 2.86 | 2.22 |
P/TBV Ratio | 3.27 | 1.18 | 2.76 | 0.73 | 2.86 | 2.22 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 82.50 | 19.60 | 67.61 | 14.40 | 96.27 | 12.69 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.02 | 0.05 | 0.10 | 0.06 | 0.08 | 0.05 |
Net Debt / Equity Ratio | -0.84 | -0.71 | -0.44 | -0.72 | -0.53 | -0.74 |
Net Debt / EBITDA Ratio | 2.85 | 1.19 | 0.40 | 1.68 | 1.15 | 3.23 |
Net Debt / FCF Ratio | 4.82 | 1.51 | 0.41 | 2.61 | 1.00 | 4.25 |
Asset Turnover | 0.04 | 0.05 | 0.02 | 0.03 | 0.02 | 0.12 |
Quick Ratio | 8.49 | 3.64 | 1.36 | 3.03 | 4.37 | 5.40 |
Current Ratio | 8.49 | 3.66 | 1.38 | 3.05 | 4.39 | 5.42 |
Return on Equity (ROE) | -46.51% | -69.74% | -73.97% | -43.50% | -37.46% | -29.84% |
Return on Assets (ROA) | -22.63% | -31.43% | -34.76% | -22.21% | -19.43% | -15.27% |
Return on Invested Capital (ROIC) | -182.06% | -171.45% | -203.28% | -121.40% | -107.49% | -79.32% |
Return on Capital Employed (ROCE) | -28.80% | -56.90% | -103.20% | -40.50% | -43.00% | -21.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -17.29% | -51.44% | -38.71% | -56.14% | -16.09% | -10.11% |
FCF Yield | -5.34% | -39.97% | -38.99% | -37.50% | -18.53% | -7.81% |
Buyback Yield / Dilution | -203.20% | -25.08% | -88.71% | -8.44% | -5.53% | -117.45% |